Clinical Feasibility and Safety of Scleral Collagen Cross-Linking by Riboflavin and Ultraviolet A in Pathological Myopia Blindness: A Pilot Study

Clinical Feasibility and Safety of Scleral Collagen Cross-Linking by Riboflavin and Ultraviolet A in Pathological Myopia Blindness: A Pilot Study

Abstract Introduction To investigate the feasibility and safety of scleral ultraviolet A (UVA) cross-linking (scleral CXL) on pathologically blindness. Methods This was a prospective, observational clinical study. Five patients with monocular blindness due to pathological myopic maculopathy were enr...

Full description

Bibliographic Details
Main Authors: Yu Li, Yue Qi, Mingshen Sun, Changbin Zhai, Wenbin Wei, Fengju Zhang
Format: Article
Language:English
Published: Adis, Springer Healthcare 2022-12-01
Series:Ophthalmology and Therapy
Subjects:
Clinic
Cross-linking
Pathological myopia
Safety
Sclera
Online Access:https://doi.org/10.1007/s40123-022-00633-5

Internet

https://doi.org/10.1007/s40123-022-00633-5

Similar Items